The hospital operator and medication provider Fresenius is starting to sell its first stores as part of the company’s restructuring.
The DAX group Fresenius is selling its 70 percent stake in the operator of the Clinica Ricardo Palma hospital in the capital Lima. Buyers are previous shareholders and other local investors, as Fresenius announced on Tuesday. The sale is expected to close in the first quarter of 2024. Information about the selling price was not provided.
Fresenius boss Michael Sen wants to concentrate on the Helios clinic chain and the Kabi pharmaceutical division when restructuring the healthcare group. He sees the dialysis subsidiary Fresenius Medical Care and the clinic service provider Vamed only as financial investments. Peripheral businesses are also to be sold in order to reduce the high level of corporate debt.
Sen said in the spring that Fresenius would divest from a “handful” of businesses. There is also speculation, among other things, about the sale of the Eugin Group’s fertility clinics and the software provider Curalie, which specializes in health apps. This Thursday Fresenius will publish its third quarter figures.
Via XETRA, Fresenius shares temporarily gained 0.54 percent to 24.41 euros.
/tav/mis/stk
BAD HOMBURG (dpa-AFX)
Selected leverage products on Fresenius
With knock-outs, speculative investors can participate disproportionately in price movements. Simply select the lever you want and we will show you suitable open-end products on Fresenius
The leverage must be between 2 and 20
Advertising